The Ets-1 and Ets-2 transcription factors activate the promoters for invasion-associated urokinase and collagenase genes in response to epidermal growth factor
Open Access
- 3 July 1998
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 77 (1) , 128-137
- https://doi.org/10.1002/(sici)1097-0215(19980703)77:1<128::aid-ijc20>3.0.co;2-9
Abstract
Urokinase plasminogen activator (uPA) has been associated with invasion and metastasis in breast cancer. The expression of uPA and 92 kDa type IV collagenase (gelatinase B/MMP‐9) is regulated by growth factors, receptor‐type tyrosine kinases and cytoplasmic oncoproteins. Here, we have identified transcriptional requirements for the induction of uPA and 92 kDa type IV collagenase by epidermal growth factor (EGF). EGF stimulates the motile and invasive activities specifically in the ErbB‐2‐overexpressing SK‐BR‐3 cells. Expression of extracellular matrix‐degrading proteases including type I collagenase/MMP‐1, 92 kDa type IV collagenase/MMP‐9, uPA and uPA receptor were induced. EGF also transiently stimulated expression of the transcription factors Ets‐1 and Ets‐2. Reporter transfection assays revealed the activation of uPA and MMP‐9 collagenase promoters by EGF and the requirement of each of the composite Ets and AP‐1 transcription factor binding sites for an EGF response. Most notably, transfections with the Ets‐1 and Ets‐2 expression vectors potentiated uPA and MMP‐9 promoter activation in response to EGF. Mutation of the threonine 75 residue of chicken Ets‐2 conserved in the Pointed group of the Ets family proteins abrogated the ability of Ets‐2 to collaborate with EGF. Ets‐1 and Ets‐2 were highly expressed in invasive breast tumor cell lines. Our results suggest that Ets‐1 and Ets‐2 provide the link connecting EGF stimuli with activation of uPA and 92 kDa type IV collagenase promoters and may contribute to invasion phenotypes. Int. J. Cancer 77:128–137, 1998.Keywords
This publication has 37 references indexed in Scilit:
- HER2/Neu and the Ets transcription activator PEA3 are coordinately upregulated in human breast cancerOncogene, 1997
- ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signalingThe EMBO Journal, 1997
- Two Transcription Factors, E1AF and N‐myc, Correlate with the Invasiveness of Neuroblastoma Cell LinesJapanese Journal of Cancer Research, 1997
- Conserved mechanisms of Ras regulation of evolutionary related transcription factors, Ets1 and Pointed P2Oncogene, 1997
- Stimulation of 92-kDa Gelatinase B Promoter Activity by ras Is Mitogen-activated Protein Kinase Kinase 1-independent and Requires Multiple Transcription Factor Binding Sites Including Closely Spaced PEA3/ets and AP-1 SequencesJournal of Biological Chemistry, 1996
- Involvement of a Mitogen-activated Protein Kinase Signaling Pathway in the Regulation of Urokinase Promoter Activity by c-Ha-rasJournal of Biological Chemistry, 1995
- The activities of two Ets-related transcription factors required for drosophila eye development are modulated by the Ras/MAPK pathwayCell, 1994
- The Ets family of transcription factorsEuropean Journal of Biochemistry, 1993
- Association of increased basement membrane invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell linesJournal of Cellular Physiology, 1992
- Increase in urokinase plasminogen activator mRNA synthesis in human carcinoma cells is a primary effect of the potent tumor promoter, phorbol myristate acetate.The Journal of cell biology, 1986